Stephen Croskrey - Mar 15, 2022 Form 4 Insider Report for Danimer Scientific, Inc. (DNMR)

Role
CEO and Chairman of the Board, Director
Signature
/s/ Stephen E. Croskrey
Stock symbol
DNMR
Transactions as of
Mar 15, 2022
Transactions value $
$0
Form type
4
Date filed
3/17/2022, 09:29 PM
Previous filing
Jan 4, 2022
Next filing
Apr 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNMR Stock Option (right to purchase) Award $0 +972K $0.00 972K Mar 15, 2022 Common Stock 972K $3.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option to purchase shares of the Issuer's Class A common stock ("Common Stock") was granted to Reporting Person on March 15, 2022 under the Danimer Scientific, Inc. 2020 Long-Term Incentive Plan (the "Plan"). Options to purchase 324,074 shares of the Issuer's Common Stock will vest and become exercisable on each of March 15, 2023, March 15, 2024 and March 15, 2025; provided, that the option will not be exercisable until the approval by the shareholders of the Issuer of an amendment to the Plan to increase the number of shares available under the Plan in an amount sufficient to permit the exercise of the option.